This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fisher, N. G. Articles by Kaul, S. Search for Related Content PubMed PubMed Citation Articles by Fisher, N. G. Articles by Kaul, S.

EXPERIMENTAL STUDY

Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent

^* Cardiovascular Imaging Center, Cardiovascular Division, University of Virginia, Charlottesville, Virginia, USA

Manuscript received June 20, 2001; revised manuscript received September 27, 2001, accepted November 7, 2001.

^* Reprint requests and correspondence: Dr. Sanjiv Kaul, Cardiovascular Division, Box 158, Medical Center, University of Virginia, Charlottesville, Virginia 22908, USA.
sk{at}virginia.edu

OBJECTIVES: This study sought to investigate the myocardial and microvascular kinetics of BR14, a novel third-generation ultrasound contrast agent.

BACKGROUND: BR14 produces persistent myocardial opacification after the administration of a single intravenous bolus when the left ventricular cavity contrast has considerably diminished. The mechanism of this finding is unknown.

METHODS: Nine open-chest dogs with non-critical stenosis of a single coronary artery were given intravenous bolus injections of BR14 during coronary hyperemia. Time versus acoustic intensity (AI) plots were generated from the normal and stenosed beds and myocardial blood flow (MBF) was measured with radiolabeled microspheres. Intravital microscopy was performed on an exteriorized cremaster muscle in 11 wild-type mice to study the microvascular kinetics of the agent.

RESULTS: At peak contrast enhancement, the ratio between AI in the stenosed and normal bed was 0.44 ± 0.23, which was similar to the radiolabeled microsphere-derived MBF ratio between the two beds (0.45 ± 0.20). At 400 s after injection, the AI ratio between the two beds approximated unity (0.99 ± 0.07) despite no changes in MBF, indicating redistribution of the agent. The myocardial kinetics of BR14 was best characterized by a modified lagged normal density function. Only about 3% of administered microbubbles were estimated to be retained in the myocardium. Intravital microscopy showed that most of these bubbles were retained only transiently (2 to 3 s) within capillaries.

CONCLUSIONS: BR14 demonstrates redistribution because of transient retention within capillaries. Therefore, similar to ²⁰¹Tl, it could potentially be used to detect both coronary stenosis and myocardial viability after a single injection during stress.

Abbreviations and Acronyms   LNDF   AI   acoustic intensity   LAD   left anterior descending coronary artery   LCx   left circumflex coronary artery   LNDF   lagged normal density function   LV   left ventricular   MBF   myocardial blood flow   MCE   myocardial contrast echocardiography

This article has been cited by other articles:

				J. C. Sullivan, B. Wang, E. I. Boesen, G. D'Angelo, J. S. Pollock, and D. M. Pollock Novel use of ultrasound to examine regional blood flow in the mouse kidney Am J Physiol Renal Physiol, July 1, 2009; 297(1): F228 - F235. [Abstract] [Full Text] [PDF]

				M. Braide, H. Rasmussen, A. Albrektsson, and U. Bagge Microvascular behavior and effects of sonazoid microbubbles in the cremaster muscle of rats after local administration. J. Ultrasound Med., July 1, 2006; 25(7): 883 - 890. [Abstract] [Full Text] [PDF]

				T. Imada, T. Tatsumi, Y. Mori, T. Nishiue, M. Yoshida, H. Masaki, M. Okigaki, H. Kojima, Y. Nozawa, Y. Nishiwaki, et al. Targeted Delivery of Bone Marrow Mononuclear Cells by Ultrasound Destruction of Microbubbles Induces Both Angiogenesis and Arteriogenesis Response Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2128 - 2134. [Abstract] [Full Text] [PDF]

				J. Yoshida, K. Ohmori, H. Takeuchi, K. Shinomiya, T. Namba, I. Kondo, H. Kiyomoto, and M. Kohno Treatment of Ischemic Limbs Based on Local Recruitment of Vascular Endothelial Growth Factor-Producing Inflammatory Cells With Ultrasonic Microbubble Destruction J. Am. Coll. Cardiol., September 6, 2005; 46(5): 899 - 905. [Abstract] [Full Text] [PDF]

				H. Takeuchi, K. Ohmori, I. Kondo, K. Shinomiya, A. Oshita, Y. Takagi, J. Yoshida, K. Mizushige, and M. Kohno Interaction with Leukocytes: Phospholipid-stabilized versus Albumin-Shell Microbubbles Radiology, March 1, 2004; 230(3): 735 - 742. [Abstract] [Full Text] [PDF]

				H. Kunichika, B. Peters, B. Cotter, H. Masugata, N. Kunichika, P. L. Wolf, and A. N. DeMaria Visualization of risk-area myocardium as a high-intensity, hyperenhanced "hot spot" by myocardial contrast echocardiography following coronary reperfusion: Quantitative analysis J. Am. Coll. Cardiol., August 6, 2003; 42(3): 552 - 557. [Abstract] [Full Text] [PDF]

				N. G. Fisher, J. P. Christiansen, A. Klibanov, R. P. Taylor, S. Kaul, and J. R. Lindner Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement J. Am. Coll. Cardiol., August 21, 2002; 40(4): 811 - 819. [Abstract] [Full Text] [PDF]

				N. G. Fisher, H. Leong-Poi, T. Sakuma, S.-J. Rim, J. P. Bin, and S. Kaul Detection of coronary stenosis andmyocardial viability using a singleintravenous bolus injection of BR14 J. Am. Coll. Cardiol., February 6, 2002; 39(3): 523 - 529. [Abstract] [Full Text] [PDF]